$IRON SEC Filings

Filed On	Filing
26 Oct 2026	SCHEDULE 13D/A
22 Oct 2026	8-K: Entry into a Material Definitive Agreement; Results of Operations and Financial Condition +1 more Disc Medicine, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) 6,000,000 shares of its common stock, par value $0.0001 per share (the “F...
21 Oct 2026	Form 4: Bitterman Kevin, Director Sold 10,994 shares ($879K) · Sold 5,312 shares ($425K) · Sold 25,519 shares ($2.05M)
21 Oct 2026	424B5
21 Oct 2026	144
21 Oct 2026	144
21 Oct 2026	144
21 Oct 2026	144
20 Oct 2026	424B5
20 Oct 2026	144
20 Oct 2026	144
20 Oct 2026	144
20 Oct 2026	144
19 Oct 2026	144
19 Oct 2026	144
19 Oct 2026	144
19 Oct 2026	144
19 Oct 2026	8-K: Regulation FD Disclosure; Other Events Disclaimer and FLS This presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, express or implied statements regarding Disc’s expectat...
16 Sep 2026	Form 4: Quisel John D, Director Received 36,000 shares by exercise or conversion ($36.4K)
15 Sep 2026	Form 4: Bitterman Kevin, Director Received 27,136 shares by exercise or conversion ($1.22M) · Sold 27,136 shares ($1.9M)

Comments